Gabon vs Myanmar: Average cost of drugs for extensively drug-resistant tuberculosis
Gabon
995 constant 2022 US$
in 2024
Myanmar
963 constant 2022 US$
in 2024
Gabon rank
42nd
Myanmar rank
43rd
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Gabon
- Myanmar
How they compare
Gabon currently reports 995 constant 2022 US$ against 963 constant 2022 US$ in Myanmar, a difference of 32 constant 2022 US$.
The two have swapped places 3 times across 5 shared years of data; in 2020 it was Myanmar ahead.
Gabon ranks 42nd and Myanmar ranks 43rd of 56 countries.
Gabon has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Gabon or Myanmar?
- Gabon, at 995 constant 2022 US$ against 963 constant 2022 US$ in Myanmar as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Gabon and Myanmar?
- 32 constant 2022 US$, with Gabon ahead.
- How many years of comparable data are there for Gabon and Myanmar?
- 5 years are reported by both, from 2020 to 2024.
- How do Gabon and Myanmar rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Gabon ranks 42nd and Myanmar ranks 43rd of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.